68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer

被引：0
作者：
Daniela A. Ferraro
Urs J. Muehlematter
Helena I. Garcia Schüler
Niels J. Rupp
Martin Huellner
Michael Messerli
Jan Hendrik Rüschoff
Edwin E. G. W. ter Voert
Thomas Hermanns
Irene A. Burger
机构：
[1] University Hospital Zurich,Department of Nuclear Medicine
[2] University of Zurich,Institute of Diagnostic and Interventional Radiology
[3] University Hospital Zurich,Department of Radiation Oncology
[4] University of Zurich,Department of Pathology and Molecular Pathology
[5] University Hospital Zurich,Department of Urology
[6] University of Zurich,Department of Nuclear Medicine
[7] University Hospital Zurich,undefined
[8] University of Zurich,undefined
[9] University Hospital Zurich,undefined
[10] University of Zurich,undefined
[11] Kantonsspital Baden,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2020年 / 47卷
关键词：
SUV; PET quantification; Lymph node metastases; PET/MR; PET/CT; Staging; Prediction model; Nomogram; Net benefit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：147 / 159
页数：12
相关论文
共 50 条
  • [21] Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate-Risk Prostate Cancer Patients With Node-Negative PSMA PET
    Esen, Baris
    Seymen, Hulya
    Armutlu, Ayse
    Koseoglu, Ersin
    Aykanat, Ibrahim Can
    Zoroglu, Hatice
    Canda, Abdullah Erdem
    Kordan, Yakup
    Balbay, Mevlana Derya
    Baydar, Dilek Ertoy
    Demirkol, Mehmet Onur
    Tilki, Derya
    Esen, Tarik
    PROSTATE, 2025, : 777 - 783
  • [22] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer
    Tulsyan, Shruti
    Das, Chandan J.
    Tripathi, Madhavi
    Seth, Amlesh
    Kumar, Rajeev
    Bal, Chandrasekhar
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1094 - 1102
  • [23] 68Ga-PSMA PET/CT based primary staging and histological correlation after extended pelvic lymph node dissection at radical prostatectomy
    Kopp, J.
    Kopp, D.
    Bernhardt, E.
    Manka, L.
    Beck, A.
    Gerullis, H.
    Karakiewicz, P.
    Schoerner, W.
    Hammerer, P.
    Schiffmann, Jonas
    WORLD JOURNAL OF UROLOGY, 2020, 38 (12) : 3085 - 3090
  • [24] 68Ga-PSMA PET/CT based primary staging and histological correlation after extended pelvic lymph node dissection at radical prostatectomy
    J. Kopp
    D. Kopp
    E. Bernhardt
    L. Manka
    A. Beck
    H. Gerullis
    P. Karakiewicz
    W. Schoerner
    P. Hammerer
    Jonas Schiffmann
    World Journal of Urology, 2020, 38 : 3085 - 3090
  • [25] Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer
    Minamimoto, Ryogo
    Hancock, Steven
    Schneider, Bernadette
    Chin, Frederick T.
    Jamali, Mehran
    Loening, Andreas
    Vasanawala, Shreyas
    Gambhir, Sanjiv Sam
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (04) : 557 - 562
  • [26] 68Ga-PSMA-11 PET and mpMRI in the diagnosis of initial lymph node staging of prostate cancer: a head-to-head comparative meta-analysis
    Wang, Yuanrong
    Jing, Ren
    Wang, Haiyan
    Zhao, Qiuyan
    FRONTIERS IN MEDICINE, 2024, 11
  • [27] Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool
    Briganti, Alberto
    Capitanio, Umberto
    Abdollah, Firas
    Gallina, Andrea
    Suardi, Nazareno
    Bianchi, Marco
    Tutolo, Manuela
    Salonia, Andrea
    Freschi, Massimo
    Rigatti, Patrizio
    Montorsi, Francesco
    PROSTATE, 2012, 72 (05) : 499 - 506
  • [28] Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence
    Calais, Jeremie
    Fendler, Wolfgang P.
    Eiber, Matthias
    Gartmann, Jeannine
    Chu, Fang-I
    Nickols, Nicholas G.
    Reiter, Robert E.
    Rettig, Matthew B.
    Marks, Leonard S.
    Ahlering, Thomas E.
    Huynh, Linda M.
    Slavik, Roger
    Gupta, Pawan
    Quon, Andrew
    Allen-Auerbach, Martin S.
    Czernin, Johannes
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 434 - 441
  • [29] 68Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?
    Christian Uprimny
    Wiener Medizinische Wochenschrift, 2019, 169 : 3 - 11
  • [30] Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
    Kesler, Mikhail
    Cohen, Dan
    Levine, Charles
    Sarid, David
    Keizman, Daniel
    Yossepowitch, Ofer
    Even-Sapir, Einat
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (07) : 1030 - 1035
12345